Tue, July 18, 2023
Mon, July 17, 2023
Fri, July 14, 2023

Pete Stavropoulos Reiterated (ABOS) at Buy and Held Target at $13 on, Jul 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-13-on-jul-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Pete Stavropoulos of Cantor Fitzgerald, Reiterated "Acumen Pharmaceuticals, Inc." (ABOS) at Buy and Held Target at $13 on, Jul 17th, 2023.

Pete has made no other calls on ABOS in the last 4 months.



There is 1 other peer that has a rating on ABOS. Out of the 1 peers that are also analyzing ABOS, 0 agree with Pete's Rating of Hold.



This is the rating of the analyst that currently disagrees with Pete


  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 28th, 2023

Publication Contributing Sources